| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Australia | 3 | |
| #4 | Canada | 3 | |
| #5 | Finland | 1 | |
| #6 | Japan | 1 | |
| #7 | Norway | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Sugars | |
| #5 | Fermentation | |
| #6 | Microorganisms | |
| #7 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Teng Nelson | 7 |
| #2 | Bhattacharjee Apurba | 7 |
| #3 | Sadoff Jerald | 6 |
| #4 | Shafferman Avigdor | 4 |
| #5 | Fattom Ali Ibrahim | 4 |
| #6 | Karakawa Walter W | 4 |
| #7 | Wright D Craig | 4 |
| #8 | Naso Robert B | 4 |
| #9 | Sadoff Jerald C | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO9505196A1 | Antibody-based treatment of hiv infection | |
| EP0648127A1 | Type i surface antigens associated with staphylococcus epidermidis | |
| EP0575517A1 | Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins | |
| AU7033391A | HIV-1 ENV fragment fusion protein | |
| AU6079590A | Lipid A analog/immunogenic carrier conjugates and the use thereof as vaccines |